Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Tetrathiomolybdate
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Weill Medical College of Cornell University